LRPAP1 and age-related macular degeneration: This difference could be because the retinal specialists considered the nAMD subtypes (i.e., PCV, RAP, and other typical AMD) when predicting recurrence based solely on pre-injection images, whereas the AI model made predictions without considering these subtypes.